Lisa M Kattenhorn (Lisa Kattenhorn)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Squamous Cell Carcinoma

Top Venues

Toxicologic pathology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Funda Meric-Bernstam, Randy F Sweis, Stefan Kasper, Omid Hamid, Shailender Bhatia, Reinhard Dummer, Agostina Stradella, Georgina V Long, Anna Spreafico, Toshio Shimizu, Neeltje Steeghs, Jason John Luke, Sarah M McWhirter, Thomas Müller, Nitya Nair, Nancy Lewis, Xinhui Chen, Andrew Bean, Lisa M Kattenhorn, Marc R Pelletier, Shahneen Sandhu
Combination of the STING Agonist MIW815 and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-label, Multicenter, Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Julie A Hutt, Basel T Assaf, Brad Bolon, Joy Cavagnaro, Elizabeth Galbreath, Branka Grubor, Lisa M Kattenhorn, Annette Romeike, Laurence O Whiteley
Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vectors. Toxicologic pathology (2021)